Nigeria, others to begin Lassa fever vaccine clinical trials The Punch
Published 29 June 2021
The United States of America has said that a new phase of Lassa fever vaccine clinical trials is set to begin in Nigeria, Liberia and Sierra Leone.
This was disclosed in a statement on Monday by the Public Affairs Unit of the United States Diplomatic Mission to Nigeria.
According to the statement, the International AIDS Vaccine Initiative was awarded €22.8m by the European and Developing Countries Clinical Trial Partnership and the Coalition for Epidemic Preparedness Innovations to conduct a Phase IIB trial of the IAVI Lassa fever vaccine candidate among adults and children in Nigeria, Liberia and Sierra Leone.
In South Africa, COVID-19 Pits Traditional Medicine Against Clinical Trial Rules 31/12/2020
In June,
Artemisia afra was in high demand on the streets of Johannesburg in South Africa. To treat COVID-19 symptoms, the Indigenous herb’s silvery leaves were for sale at roadside vendors and in the city’s popular traditional markets. Some people even pulled the plant from private gardens. And on the sides of nearby highways, people held signs for “mhlonyane” (
A. afra’s isiZulu name) and offered bushels to passing motorists like bouquets. Between February and July, the herb doubled in price.
People in the region have consumed the bitter plant for centuries to treat illnesses from colds to intestinal worms. With deaths rising as South Africa battled its first COVID-19 wave, people have turned to
Bringing Traditional Healing Under the Microscope in South Africa medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.